ZYXI
Zynex, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$0.13
+140.38%Year over year
Reported trailing growth
- Revenue
- -44.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +13.9%
- EBITDA
- -24.1%
- EBIT
- -35.5%
- Net income
- -44.1%
- EPS
- -39.7%
- Free cash flow
- +24.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025